Baltimore Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Baltimore Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$1.46M	Buy	+30,595	New	+$1.52M	2.36%	15
2018 Q3	$1.58M	Sell	25,420 -225	-0.9%	-$13.4K	2.54%	14
2018 Q2	$1.42M	Buy	25,645 +1,560	+6%	+$84.3K	2.1%	15
2018 Q1	$1.52M	Sell	24,085 -265	-1%	-$17K	2.28%	14
2017 Q4	$1.49M	Sell	24,350 -500	-2%	-$31.3K	2.1%	16
2017 Q3	$1.58M	Buy	24,850 +500	+2%	+$29.2K	2.23%	15
2017 Q2	$1.36M	Buy	24,350 +610	+3%	+$33.2K	1.96%	16
2017 Q1	$1.29M	Buy	+23,740	New	+$1.3M	1.72%	22

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Baltimore Capital Management's BMY Position: Q1 2019 in Review

Baltimore Capital Management opened a new position in Bristol-Myers Squibb (BMY) in Q1 2019: 30,595 shares worth $1.46M. The stake represents 2.36% of the portfolio and ranks #15 among its holdings. This is a return to the name: Baltimore Capital Management previously reported a position in BMY as recently as Q3 2018.

Baltimore Capital Management first reported a position in BMY in Q1 2017 and has held it in 8 quarters since. The position peaked at $1.58M in Q3 2017. 1,813 funds tracked by Wall St. Rank hold BMY as of Q1 2019.

Baltimore Capital Management held 30,595 shares of Bristol-Myers Squibb worth $1.46M as of Q1 2019.
Bristol-Myers Squibb was a new Baltimore Capital Management position in Q1 2019.
Bristol-Myers Squibb made up 2.36% of Baltimore Capital Management's portfolio in Q1 2019, its #15 holding.
Baltimore Capital Management first reported a position in Bristol-Myers Squibb in Q1 2017 and has held it in 8 quarters since.
Baltimore Capital Management's Bristol-Myers Squibb position peaked at $1.58M in Q3 2017.
1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.

Based on Baltimore Capital Management's 13F filing for Q1 2019, filed 14 May 2019.